Advanced in Hemophilia B

Dr. Frederico C. Xavier

Pediatric Hematology Oncology
Hemophilia Center Of Western PA
201 N Craig St, Suite 500, 
Pittsburgh, PA 

Advanced in Hemophilia B
Hemophilia Center Of Western PA
201 N Craig St, Suite 500, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Frederico Xavier is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Xavier is rated as an Advanced provider by MediFind in the treatment of Hemophilia B. His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemophilia B.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

HEMOPHILIA CENTER OF WESTERN PA
201 N Craig St, Suite 500, Pittsburgh, PA 15213
Call: 412-209-7280

Additional Areas of Focus

Dr. Xavier has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other
Study Phase: Phase 3
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Enrollment Status: Terminated
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: Von Willebrand Factor, Tranexamic Acid
Study Phase: Phase 3
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: April 11, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: February 21, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Enrollment Status: Withdrawn
Publish Date: August 20, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

29 Total Publications

Targeted Treatment With Alpelisib for Papillary Intralymphatic Angioendothelioma Associated With Somatic PIK3CA Mosaicism.
Targeted Treatment With Alpelisib for Papillary Intralymphatic Angioendothelioma Associated With Somatic PIK3CA Mosaicism.
Journal: Pediatric blood & cancer
Published: June 16, 2025
View All 29 Publications
Similar Doctors
A K. Ritchey
Advanced in Hemophilia B
Dr. A K. Ritchey
Pediatric Hematology Oncology
Advanced in Hemophilia B
Dr. A K. Ritchey
Pediatric Hematology Oncology

UPMC Children's Hospital Of Pittsburgh, Pediatric Hematology/Oncology

4401 Penn Avenue, Floor 3, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology. Dr. Ritchey is rated as an Advanced provider by MediFind in the treatment of Hemophilia B. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hemophilia B, Hemophilia A, and Leukemia.

Experienced in Hemophilia B
Dr. Steven Fein
Pediatric Hematology Oncology
Experienced in Hemophilia B
Dr. Steven Fein
Pediatric Hematology Oncology

University Of Pittsburgh Physicians

200 Lothrop St, Muh 4 East, 
Pittsburgh, PA 
 (1.7 miles away)
412-383-1370
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Fein is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Fein is rated as an Advanced provider by MediFind in the treatment of Hemophilia B. His top areas of expertise are Alpha Thalassemia, Blood Clots, Anemia, Bone Marrow Aspiration, and Splenectomy.

VIEW MORE HEMOPHILIA B DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Xavier's expertise for a condition
ConditionClose
    • Distinguished
    • Hemophilia A
      Dr. Xavier is
      Distinguished
      . Learn about Hemophilia A.
      See more Hemophilia A experts
    • Hemophilic Arthropathy
      Dr. Xavier is
      Distinguished
      . Learn about Hemophilic Arthropathy.
      See more Hemophilic Arthropathy experts
    • Advanced
    • Blood Clots
      Dr. Xavier is
      Advanced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Hemophilia B
      Dr. Xavier is
      Advanced
      . Learn about Hemophilia B.
      See more Hemophilia B experts
    • Von Willebrand Disease (VWD)
      Dr. Xavier is
      Advanced
      . Learn about Von Willebrand Disease (VWD).
      See more Von Willebrand Disease (VWD) experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.